Literature DB >> 15135126

Asthma phenotypes in childhood: lessons from an epidemiological approach.

Renato T Stein1, Fernando D Martinez.   

Abstract

Asthma is a heterogenous disease with variable signs and symptoms among patients. It also presents significant individual variability over time. Recently, some important population-based studies that followed children from birth or from early childhood into adulthood have shed new light on how we understand this syndrome. Three phenotypes have been identified in children with asthma: transient wheezing, non-atopic wheezing of the toddler and pre-school-aged child and IgE-mediated wheezing. Transient wheezing is associated with symptoms that are limited to the first 3-5 years of life, decreased lung function, maternal smoking during pregnancy and exposure to other siblings or children at daycare centres. There is no association between transient wheezing and family history of asthma or allergic sensitisation. Children wheezing with respiratory syncytial virus in the first years of life are more likely to be wheezing up to 13 years of age; this is independent of atopy (non-atopic wheezers) and is not related to atopic sensitisation. Wheezing associated with evidence of allergic sensitisation has been identified as the 'classic' asthma phenotype. Early allergic sensitisation is a major risk factor for persistent asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135126     DOI: 10.1016/j.prrv.2004.01.007

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  44 in total

1.  Wheezing, asthma, hay fever, and atopic eczema in relation to maternal occupations in pregnancy.

Authors:  L L Magnusson; H Wennborg; J P Bonde; J Olsen
Journal:  Occup Environ Med       Date:  2006-06-06       Impact factor: 4.402

2.  Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Yury A Bochkov; James E Gern; Pedro A Piedra; Cindy S Bauer; Stephen J Teach; Susan Wu; Ashley F Sullivan; Carlos A Camargo
Journal:  JAMA Pediatr       Date:  2019-06-01       Impact factor: 16.193

3.  Point-counterpoint. The triumph of the null hypothesis: epidemiology in an age of change.

Authors:  Wasim Maziak
Journal:  Int J Epidemiol       Date:  2008-12-17       Impact factor: 7.196

4.  Variation in ITGB3 is associated with asthma and sensitization to mold allergen in four populations.

Authors:  Lauren A Weiss; Lucille A Lester; James E Gern; Raoul L Wolf; Rodney Parry; Robert F Lemanske; Julian Solway; Carole Ober
Journal:  Am J Respir Crit Care Med       Date:  2005-04-07       Impact factor: 21.405

5.  Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study.

Authors:  Oystein Karlstad; Per Nafstad; Aage Tverdal; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Clin Pharmacol       Date:  2009-11-21       Impact factor: 2.953

6.  Role of infections in the induction and development of asthma: genetic and inflammatory drivers.

Authors:  Qun Wu; Hong Wei Chu
Journal:  Expert Rev Clin Immunol       Date:  2009-01-01       Impact factor: 4.473

7.  Risk of idiopathic nephrotic syndrome among children with asthma: a nationwide, population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Yu-Fen Li
Journal:  Pediatr Res       Date:  2015-04-30       Impact factor: 3.756

Review 8.  Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.

Authors:  Kevin Tse; Anthony A Horner
Journal:  Semin Immunopathol       Date:  2007-11-08       Impact factor: 9.623

9.  MMP-9 gene variants increase the risk for non-atopic asthma in children.

Authors:  Leonardo A Pinto; Martin Depner; Norman Klopp; Thomas Illig; Christian Vogelberg; Erika von Mutius; Michael Kabesch
Journal:  Respir Res       Date:  2010-02-24

10.  Risk factors for atopic and non-atopic asthma in a rural area of Ecuador.

Authors:  Ana Lucia Moncayo; Maritza Vaca; Gisela Oviedo; Silvia Erazo; Isabel Quinzo; Rosemeire L Fiaccone; Martha E Chico; Mauricio L Barreto; Philip J Cooper
Journal:  Thorax       Date:  2010-05       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.